VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 126 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $45,456,516 | +49.3% | 2,963,267 | +131.6% | 1.76% | +24.6% |
Q2 2023 | $30,439,353 | -2.7% | 1,279,502 | +4.0% | 1.41% | +9.6% |
Q1 2023 | $31,297,789 | -39.5% | 1,230,259 | -30.5% | 1.28% | -40.8% |
Q4 2022 | $51,735,408 | +28.0% | 1,771,154 | -10.1% | 2.17% | +17.3% |
Q3 2022 | $40,411,000 | +198.5% | 1,970,290 | +68.4% | 1.85% | +108.0% |
Q2 2022 | $13,540,000 | -37.4% | 1,170,290 | 0.0% | 0.89% | -35.9% |
Q1 2022 | $21,639,000 | -18.1% | 1,170,290 | -12.4% | 1.39% | -25.6% |
Q4 2021 | $26,426,000 | – | 1,336,690 | – | 1.87% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 2,699,865 | $68,684,566 | 13.41% |
COMMODORE CAPITAL LP | 2,189,659 | $55,704,925 | 8.48% |
Fairmount Funds Management LLC | 1,369,623 | $34,843,209 | 5.99% |
Paradigm Biocapital Advisors LP | 2,085,698 | $53,060,157 | 5.03% |
Octagon Capital Advisors LP | 1,185,000 | $30,146,400 | 4.34% |
Logos Global Management LP | 950,000 | $24,168,000 | 3.46% |
TCG Crossover Management, LLC | 663,610 | $16,882,238 | 3.29% |
ACUTA CAPITAL PARTNERS, LLC | 168,000 | $4,273,920 | 3.15% |
Vivo Capital, LLC | 1,678,207 | $42,693,586 | 2.96% |
TANG CAPITAL MANAGEMENT LLC | 692,925 | $17,628,012 | 2.63% |